On February 17th 2026 the USDA-Economic Research Service released updated production and consumption data with respect to broilers and turkeys, covering actual 2024, a projection for 2025 and a forecast for 2026.

The revised 2025 projection for broiler production is for 48,003 million lbs. (21.770 million metric tons) up 2.1 percent from 2024. USDA projected per capita consumption of 102.9 lbs. (45.7 kg.) for 2025, up 1.8 percent from 2024. Exports will attain 6,660 million lbs. (3.020 million metric tons), 0.3 percent below the previous year.

The 2026 USDA forecast for broiler production will be 48,500 million lbs. (21.996 million metric tons) up 1.0 percent from 2025 with per capita consumption up 0.9 percent to 103.8 lbs. (46.6 kg). Exports will be 1.5 percent higher compared to 2025 at 6,670 million lbs. (3.025 million metric tons), equivalent to 13.8 percent of production.

Production values for the broiler and turkey segments of the U.S. poultry meat industry are tabulated below:-

Source: Livestock, Dairy and Poultry Outlook released Feb 17th 2026

The February 17th USDA report updated the projection for the turkey industry during 2025 including annual production of 4,844 million lbs. (2.197 million metric tons), down 5.4 percent from 2024. Consumption in 2025 is projected to be 13.2 lbs. (6.0kg.) per capita, down by 4.3 percent from the previous year. Export volume will attain 417 million lbs. (189,116 metric tons) in 2025. Values for production and consumption of RTC turkey in 2025 and 2026 are considered to be realistic, given year to date data, the prevailing economy, variable weekly poult placements, trends in production levels, losses from HPAI and inventories consistent with season.

The 2026 forecast for turkey production is 4,965 million lbs. (2.251 million metric tons) up an optimistic 2.5 percent from 2025 with per capita consumption up 1.5 percent to 13.4 lbs. (6.1 kg). Exports will be 4.1 percent lower than in 2025 to 400 million lbs. (181,406 metric tons) equivalent to 8.0 percent of production. This implies a reduction in selling prices for whole birds and products

Export projections do not allow for a breakdown in trade relations with existing major partners including Mexico, Canada and China nor the impact of catastrophic diseases including HPAI and vvND in either the U.S. or importing nations

OVERVIEW

Total exports of bone-in broiler parts and feet during January-November 2025 attained 2,868,161 metric tons, 4.0 percent lower than in January-November 2024 (2,986,653 metric tons). Total value of broiler exports decreased by 0.6 percent to $4,281 million ($4,307 million).

Total export volume of turkey products during January-November 2025 attained 173,676 metric tons, 14.8 percent less than in January-November 2024 (203,861 metric tons). Total value of turkey exports increased by 15.9 percent to $715 million ($617 million).

Average unit price attained by the broiler industry is constrained by the fact that leg quarters comprise over 96 percent of broiler meat exports by volume (excluding feet). Leg quarters represent a relatively low-value undifferentiated commodity lacking in pricing power. Exporters of commodities are subjected to competition from domestic production in importing nations. Generic products such as leg quarters are vulnerable to trade disputes and embargos based on real or contrived disease restrictions. To increase sales volume and value the U.S. industry will have to become more customer-centric offering value-added presentations with attributes required by importers. Whether this will increase margins is questionable given that leg quarters are regarded by U.S. integrators as a by-product of broiler production. A more profitable long-term strategy for the U.S. industry would be to develop products using dark meat to compete with and displace pork and beef in the domestic retail and institutional markets. Due to a shortage and hence high price for beef products this opportunity is now evident.

HPAI is now accepted to be panornitic affecting the poultry meat industries of six continents with seasonal and sporadic outbreaks. The incidence rate and location of cases in the U.S. has limited the eligibility for export from many plants depending on restrictions imposed by importing nations. Incident cases in the U.S. continued at a low rate in egg-production flocks and in turkeys during late 2025 but a resurgence is evident during the first quarter of 2026.

Uncertainty surrounding tariff policy is an added complication potentially impacting export volume in 2026. In the event of reduced exports, leg quarters would be diverted to the domestic market resulting in a depression in average value derived from a processed bird.

To offset an anticipated decline in exports of U.S. agricultural products the USDA will make available $285 million during 2026 for trade promotion including trade reciprocity missions and credit guarantees under the GSM-102 program. The USAPEEC received $7.0 million for export promotion for FY 2026. Of this total, $5.8 million was through the Market Access Program (MAP) and $1.2 million through the Foreign Market Development Program (FMDP). For FY 2026 The USDA will distribute $181 million among 68 industry associations under the MAP and $31 million under the FMDP to 18 organizations.

EXPORT VOLUMES AND PRICES FOR BROILER MEAT

The following table prepared from USDA data circulated by the USAPEEC, compares values for poultry meat exports during January-November 2025 compared with the corresponding months during 2024:-

                  COMPARISON OF U.S. CHICKEN AND TURKEY EXPORTS

                                    JANUARY-NOVEMBER 2025 COMPARED TO 2024

BROILER EXPORTS

Total broiler parts, predominantly leg quarters but including feet, exported during January-November 2025 compared with the corresponding months in 2024 declined by 4.0 percent in volume and value was down 0.6 percent. Unit value was 3.5 percent higher to $1,492 per metric ton.

For comparison during 2024 exports attained 3,251,000 metric tons valued at $4,689 million, down 10.5 percent in volume and down 1.1 percent in value compared to 2023. Unit value was up 10.7 percent to $1,442 per metric ton

Broiler imports in 2025 are projected to attain an inconsequential 67,000 metric tons (134 million lbs.) compared to 82,000 metric tons (180,000 million lbs.) in 2024

The top five importers of broiler meat represented 50.2 percent of shipments during January-November 2025. The top ten importers comprised 66.2 percent of the total volume reflecting concentration among the significant importing nations.

Third-ranked Cuba imported 209,639 metric tons over 11 months representing 7.3 percent of shipments that were valued at $265 million with a unit price of $1,264 per metric ton. Volume and value were respectively 7.3 and 6.4 percent lower than for the corresponding period in 2024. Continued trade with Cuba is imperiled by declining economic strength. Their capicity to import was recently exacerbated by the energy crisis resulting from action in Venezuela and U.S. policy on the supply of fuel to the nation.

Eighth-ranked China declined 44.7 percent in volume to 85,183 tons and concurrently by 31.3 percent in value to $262 million over the first eleven months of 2025 compared to the corresponding period in 2024. Unit value increased by 15.0 percent to $3,075 per metric ton reflecting the high proportion of feet in consignments

Nations gaining in volume compared to the corresponding period in 2024 (with the percentage change indicated) in descending order of volume with ranking indicated by numeral were:-

2. Taiwan, (+29%); 4. Philippines, (+29%); 5. Canada, (+12%); 10. UAE, (+5);             11.Ghana, (+18%); 12. Haiti, (+25%); 13, Dominican Rep., (+5%) and 16. Congo-Kinshasa), (+101%)

Losses during January-November 2025 offset the gains in exports with declines for:-

1. Mexico, (-7%); 3. Cuba, (-9%); 6. Guatemala, (-2%); 7. Angola, (-15%);

8. China, (-45%); 9. Viet Nam, (-33); 14. Hong Kong, (-36%) and 15. Columbia, (-2 %).         

TURKEY EXPORTS

The volume of turkey meat exported during January-November 2025 declined by 14.8 percent to 173,676 metric tons from the 11 months of 2024 but value was 15.9 percent higher at $715 million. Average unit value was 36.0 percent higher at $4,115 per metric ton.

Imports of turkey products attained 15,000 metric tons (33 million lbs.) in 2024 with a similar projection for 2025.

Mexico imported 137,717 tons during the 11-month period representing 79.3 percent of volume. Value attained $578 million comprising 79.5 percent of revenue at a unit price of $4,124 per ton. Canada imported 5,654 tons (3.3 percent of exports) valued at $20 million with a unit price of $3,573 per ton. 

It is important to recognize that exports of chicken and turkey meat products to our USMCA partners amounted to $1,264 million in 2021, $1,647 million during 2022, $1,696 in 2023 and $1,887 million over the first eleven months of 2025. It will be necessary for all three parties to the USMCA to respect the terms of the Agreement in good faith since punitive action against Mexico or Canada on issues unrelated to poultry products will result in reciprocal action by our trading partners to the possible detriment of U.S. agriculture.

 The emergence of H5N1strain avian influenza virus with a Eurasian genome in migratory waterfowl in all four Flyways of the U.S. during 2022 was responsible for sporadic outbreaks of avian influenza in backyard flocks and serious commercial losses in egg-producing complexes and turkey flocks but to a lesser extent in broilers. The probability of additional outbreaks of HPAI over succeeding weeks appears likely with recorded outbreaks in turkey farms in ND, SD and MN. Consistent with fall migration of waterfowl. Incident cases affecting egg-production and turkey flocks will be a function of shedding by migratory and domestic birds and possibly free-living mammals or even extension from dairy herds. Protection of commercial flocks at present relies on the intensity and efficiency of biosecurity including wild-bird laser repellant installations, representing investment in structural improvements and operational procedures. These measures are apparently inadequate to provide absolute protection, suggesting the need for preventive vaccination in high-risk areas for egg-producing, breeder and turkey flocks.

The application of restricted county-wide embargos following the limited and regional cases of HPAI in broilers with restoration of eligibility 28 days after decontamination has supported export volume for the U.S. broiler industry. Exports of turkey products were more constrained with plants processing turkeys in Minnesota, the Dakotas, Wisconsin and Iowa impacted.  The future challenge will be to gain acceptance for limited preventive vaccination of laying hens and turkeys in high-risk areas accompanied by intensive surveillance. It is now accepted that H5N1 HPAI is panornitic in distribution among commercial and migratory birds across six continents. The infection is now seasonally or regionally endemic in many nations with intensive poultry production, suggesting that vaccination will have to be accepted among trading partners as an adjunct to control measures in accordance with WOAH policy.

The live-bird market system supplying metropolitan areas, the presence of numerous backyard flocks, gamefowl and commercial laying hens allowed outside access, potentially in contact with migratory and now some resident bird species, all represent an ongoing danger to the entire U.S. commercial industry. The live-bird segments of U.S. poultry production represent a risk to the export eligibility of the broiler and turkey industries notwithstanding WOAH compartmentalization for breeders and regionalization (zoning) to counties or states for commercial production.

In a February 17th announcement, Hormel Foods Corp. confirmed that it will sell the Melrose, MN. Whole-bird plant and the Swanville, MN. feed mill and related assets including vehicles to Life-Science Innovations.  The purchaser will assume contracts with growers and provide Hormel with turkey meat through to the end of Fiscal 2026.  Hormel will retain the Jennie-O brand and will concentrate on further-processed and turkey-derived added-value products.  As motivation for the transaction, Hormel noted concern over fluctuation in commodity markets and the losses associated with HPAI that have impacted central Minnesota.

In recent years, reorganization by Hormel has obscured any evaluation of the financial performance of the Jennie-O business.  Hormel noted in their release that the divestment would have no material impact on FY 2026 earnings.  In a preliminary first quarter 2026 release on February 17th, the company expects Q1 net sales of $3 billion, organic net sales growth of two percent and Q1 diluted EPS of $0.33.  Jeff Ettinger, Interim CEO, stated “We are pleased with our preliminary first quarter results.”  He added, “They reflect a solid start to the year and are aligned with our expectations and give us confidence that we are focused on the right initiatives to return Hormel Foods to profitable growth.”

On January 22nd, a class-action lawsuit was filed against Costco Wholesale Corp., et. al, in the U.S. District Court for the Southern District of California.  The Plaintiffs, Johnston, et. al, claim that the Costco “No preservative” claim for Kirkland Signature Seasoned Rotisserie Chicken was misleading.  Carrageenan, a natural compound extracted from seaweed and sodium phosphate, a common chemical used in food processing, were added to the product as a stabilizer and preservative respectively to extend quality and shelf stability. The Plaintiffs allege that Costco took advantage of consumers seeking “clean label” descriptors of the product.

Following filing of the lawsuit, Costco amended the label of their $4.99 iconic rotisserie chicken. The company stated, “To maintain consistency among the labeling on our rotisserie chicken and the signs in our warehouses and on-line presentations, we removed statements concerning preservatives.”

Wesley Griffith, Esq., managing partner of the Almeida Law Group, the plaintiff’s attorney commented, “It is confirmation of our core legal theory that “the no preservative” claims were false. 

This case exemplifies the mendacity of the California tort bar that constantly searches for “shake-down” cases in which Plaintiffs do not suffer any damage but take advantage of them and defendants in pursuing spurious claims.  Both sodium phosphate and carrageenan improve the organoleptic qualities of product and are approved for use in food processing.

A second legal issue confronting Costco relates to the levels of Salmonella as documented by the USDA FSIS in chicken produced at Lincoln Premium Poultry. This complex is owned by Costco and is the supplier of a high proportion of rotisserie chickens sold in Costco warehouses.  Two lawsuits have been filed to date relating to contamination although there is no epidemiologic evidence that outbreaks of salmonellosis have occurred as a result of consuming Costco rotisserie chicken.  The second lawsuit filed in the U.S. District Court in Seattle on February 12th alleges “economic injury” by overpaying for the potentially contaminated chicken purchased after January 1st, 2019, the year of inception of production by Lincoln Premium Poultry. The complaint draws heavily on a December 2025 document prepared by Farm Forward, an activist group opposed to all forms of intensive livestock production.   It is a matter of record that Lincoln Premium Poultry has been classified by the USDA among Category 3 plants over an extended period. This suggests structural and operational problems that should be addressed to enable the plant to conform to industry norms with respect to contamination of carcasses and parts.

Previously, Costco was embroiled in claims and litigation arising from salmonellosis but the chicken in question was supplied by a West Coast integrator and preceded the establishment of Lincoln Premium Poultry. 

Given the possibility of viable Salmonella being present on uncooked carcasses and parts, it is necessary for consumers, restaurants and especially for in-store rotisserie preparation of chicken to ensure that appropriate handling and heating to 165 F for at least 30 seconds is achieved.  Given the sale of two million rotisserie chickens each week from Liberty Premium Poultry in Costco warehouses, the absence of Salmonella outbreaks attributed to the product, it is to be assumed that Costco is adequately cooking their rotisserie chicken and selling a wholesome product.

The allegations contained in the Farm Forward release relating to stocking density, scale of operation and management of flocks contributing to Salmonella contamination are essentially spurious. The contentions of the author represent oft-repeated and scientifically unsubstantiated opinions of Animal rights activists that lack merit. Unfortunately the statements supported by plaintiffs’ experts but will be used to sway uninformed but confused jurors.

This case has overtones of the ongoing glyphosate litigation. If unfavorable verdicts are handed down, it should be expected that a cascade of similar lawsuits will be filed targeting the largest U.S. integrators.

According to a preliminary notification in Cell Reports Medicine, a potentially effective vaccine was evaluated to protect rodents from H5N1 avian influenza infection.

The vaccine comprised a chimpanzee adenoviral virus as a vector stimulating immunity against H5 hemagglutinin antigen.  Administration of the vaccine to mice resulted in a neutralizing antibody response. Protection was demonstrated against challenge with a human-derived H5N1 isolate (A/Michigan/90/2024 clade 2.3.4.4b), presumably derived from a worker exposed to avian influenza H5N1.  The intranasal adenoviral-vectored vaccine provided a higher level of protection compared to intramuscular administration of hamsters subjected to challenge with Michigan and Texas isolates of H5N1.

It is hoped that this technology could be extended and evaluated in chickens and turkeys with an appropriate vector. The industry would benefit from any novel vaccine in addition to existing commercial vector products for mass primary immunization of broilers at the hatchery or via the intranasal route during rearing of layer and breeder pullets.

The USA Poultry and Egg Export Council was awarded $7 million by the USDA-Foreign Agricultural Service to promote exports of poultry and eggs.  USDA has now released funds allocated by Congress for both the Market Access and the Foreign Market Development programs.

In commenting on the awards, Greg Tyler, CEO of USAPEEC, stated “We are grateful to USDA- Foreign Agricultural Service for its ongoing support of our organization and global programs.”

During November 2024, the European Association of State Veterinary Offices noted that following initiation of vaccination against HPAI in ducks, outbreaks were effectively curtailed.  Through November 2024, 61 million ducks had been vaccinated with ten outbreaks compared to an anticipated 480 outbreaks that would have occurred based on losses during the 2021-2022 HPAI season.  During this period, there were 1,400 outbreaks resulting in culling of 22 million birds mainly in the concentrated foie gras industry.

Expenditure on vaccination including vaccine, administration, monitoring, surveillance and veterinary supervision amounted to $122 million but saved close to $1.5 billion that would have been expended for control and decontamination.  The $2 cost per duck appears excessive. In the context of the U.S. poultry industry, Both direct and some indirect costs would probably be less than 20 cents per bird given new-generation vector vaccines suitable for mass administration. 

Initially, the foie gras industry in France experienced negative responses from importers but it is noted that import embargos were in any event in effect due to clinical outbreaks of HPAI.

With experience and presentation of epidemiologic data and greater understanding of the ongoing HPAI pandemic, restrictions on importation from France and other nations applying HPAI vaccination have been eased.

The following were elected to executive positions on the Board of Directors of USPOULTRY during the 2026 IPPE:

• Bill Griffth, Chief Operations Officer for Peco Foods was selected as the Chairman

• Dr. Alice Johnson of Butterball LLC was elected Vice-chair

• Kevin McDaniel of Wayne-Sanderson Farms as named Treasurer

• John Wright of Fieldale Farms was elected Secretary

• Jonathan Cade of Hy-Line International will serve as the Immediate-past Chairman

In commenting on the slate of officers, Nath Morris president of USPOULTRY stated, “With the
experience and guidance these officers bring to our organization, the future of USPOULTRY is in excellent hands and I look forward to their leadership in helping to shape our organization over the next year.”

The recently released Dietary Guidelines for Americans for 2025-2030 discourages consumption of “processed foods”.  The emphasis on protein including eggs is a vindication for our industry that has undergone unjustified criticism over cholesterol content in past decades.

The question now arises as to what constitutes “processed foods.”  Various definitions have been applied but without consideration of the implications for the manufacturers of packaged products.  Applying the broadest descriptor, “processing” includes any alteration of a food from the natural state through heating, pasteurizing, mixing, milling, freezing or canning.  Within reason, these processes are essential to manufacture food products, preserve nutrient quality or to make them available to consumers.  With respect to additives, some preservatives have been shown to be both beneficial and innocuous.  Many ‘unpronounceable additives’ disfavored by purists are in fact nutrients and contribute to or are essential to health.

In a move to reject all additives in pursuit of a clean label, activists motivated by either naïve sincerity or outright mendacity risk throwing out the baby with the bath water.

Costco Wholesale Corporation (COST) is a bellwether on consumer spending and the willingness of customers to purchase food and household items in bulk and splurge on big-ticket items including appliances, electronics and furniture. On February 4th Costco reported sales for January 2026 covering the four-week period ending February 1st. Sales attained $21.33 billion, up 9.3 percent from the value of $18.51 billion during the corresponding month in 2026.

Same store sales (excluding fuel and foreign exchange) increased 6.8 percent for the U.S.; 8.2 percent for Canada and 2.7 percent for the International warehouse segment.  Overall, same-stores sales advanced by 6.4 percent and E-commerce was 33.1 percent higher. International sales were impacted by the advent of the Lunar New Year that was 19 days later than in 2025, beyond the January cut-off. Sales in this segment were depressed by an estimated 4 percent.

Costco advanced in after-hours trading on February 4th after release of the data to $988.50. COST intraday market capitalization was $434.5 billion on February 4th. The share has traded over a 52-week range of $844.06 to $1078.23.

Costco Wholesale Corporation operates 924 warehouses with 634 in the U.S.; 114 in Canada; 42 in Mexico with the remainder in nine other nations.

New World Screwworm (NWS Cochliomyia hominivorax) has seriously disrupted importation of livestock from Mexico to the U.S., directly impacting the cost of beef to consumers.  The infestation that emerged in Guatemala and spread to and then within Mexico imposes a threat to livestock producers in the U.S. states bordering our southern neighbor. On recognition of the problem surveillance and control measures were initiated emphasizing the need for cooperation among USMCA regulators.

Decades ago, the problem of NWS was resolved by releasing irradiated sterile male flies that effectively suppressed and then eliminated populations of the parasite.  Applying a “mission accomplished” approach without the necessary surveillance by our southern neighbors resulted in an inevitable reoccurrence of infection.  To address the current situation, USDA has reactivated irradiation facilities to produce and distribute sterile male flies that will be effective but over time. 

The USDA has issued a request for proposals to upgrade surveillance and control measures. Projects, even if funded and implemented will not have any immediate impact on the current emergency.  Secretary Rollins is justified in her comment, “We know we have tried-and-true tools and methods that defeat this pest, but we must constantly look for new and better methods and innovate our way to success”.

The lessons that should be heeded include:

• Constant surveillance is necessary for early detection of the parasite
• Irradiation facilities should be maintained with availability of trained personnel to rapidly respond to outbreaks.
• Cooperation with neighboring nations coupled with financial support will ensure that effective surveillance and control measures are maintained.  This is difficult to achieve in an atmosphere of hostility generated by U.S. policies relating to tariffs and immigration that detract from mutual understanding and collaboration.

At the end of the day nature ignores national boundaries and has an immense capacity to adapt to changes in the environment. These include socio-economic factors and global warming that facilitate the northward movement of pests and vectors of pathogens affecting human, animal and avian populations.

Previously EGG-NEWS reported on restatement of segment earnings by Archer-Daniels Midland Company (ADM) dating back to 2014.  Sales and contribution by the Nutrition Segment apparently were misstated by applying creative bookkeeping.  When discrepancies were disclosed, the CFO Vikram Luthar was suspended and subsequently resigned. With realization of the implications of the deviation from accepted accounting practice, ADM cooperated with the SEC and implemented “significant remedial measures”.

The SEC alleged that adjustments between the Nutrition segment and other business units of ADM were made including retroactive rebates and use of unrealistic intersegment costs to allow the Nutrition segment to meet targets for fiscal 2021 and 2022. Following extensive investigations by the company, forensic auditors and the U.S. Securities and Exchange Commission (SEC), the Company agreed to a settlement of $40 million but did not admit to any wrongdoing.  Concurrently the U.S. Department of Justice has closed its investigation.  In addition to Luthar his predecessor Ray G. Young previous CFO and Vince Macciocchi president of the Nutrition Segment and chief Sales and Marketing officer were cited by the SEC.

Juan Luciano Chair of the Board and CEO of ADM noted, “We are pleased to put these matters behind the company.  These past couple of years have underscored what is core to ADM -incorporating learnings to future strengthen our business.”

At the end of the day Luciano was ultimately responsible for the irregularities and was aware if not complicit in the financial manipulation. The incident demonstrates the downside of incentive bonuses and Boards dominated by poweful Chairpersons exercising executive action. The incident  may well denote a corporate culture inconsistent with shareholder and stakeholder interests and rigid conformity to standard accounting practices and business ethics.  As the Brits would say ADM “has form”.

Luthar still faces SEC accusations of violating antifraud provisions of securities legislation and involvement in “abetting ADM’s violation relating to internal accounting control.”  Luthar denies the SEC allegations and has not settled as have Macciocchi and Young who paid civil and disgorgement penalties.

In the weeks following the September 2024 disclosures of irregularities, ADM stock fell 30 percent from $72 to $51subsequently closing on January 29, 2026 at $67 compared to a November 2025 high of $98.  Over the past 52 weeks, ADM has traded in a range of $41 to $70 with a 50-day moving average of $61.  Operating margin is razor thin at 2.0 percent with a profit margin of 1.4 percent.  On a 12-month trailing basis, the return on assets is 1.8 percent and 5.2 percent on equity.

A collaboration among industry associations representing broilers, eggs, turkeys and ducks has resulted in establishing the Poultry Industry Food Safety Council (PIFSCo) to serve as a central clearinghouse for research and dissemination of data relating to food safety and related issues.

The Chair of PIFSCo, Kevin Atkins noted, “Food safety is the foundation of consumer trust and the key to the long-term successful industry.”  He added, “Through PIFSCo we are bringing together the best science expertise and industry collaboration to rise the standard of food safety from farm to fork.”  A new website www.pifsco.org will incorporate:-

• Educational resources

• Updates on Research

• Sharing of best practices for food safety

• Membership and participation information

Kim Rice vice-chairman of PIFSCo stated that “By uniting stakeholders across the poultry industry sectors we will help ensure consistent standards, rapid knowledge-sharing and a stronger foundation for continuous improvement.”

PIFSCo is supported by the American Egg Board, National Chicken Council, National Turkey Federation, United Egg Producers and USPOULTRY and includes representation by 50 companies and allied industry partners.

Peter McGuinness has departed from Impossible Foods after a four-year tenure.  He has accepted a position as CEO of Bel North America, the U.S. subsidiary of the Bel Group of France a major manufacturer of dairy and vegetable-based snacks and RTE foods. McGuinness will be replaced by a troika comprising Jason Gao, Chief Legal and Operating Officer, Meredith Madden, Chief Demand Officer and Robert Haas, Chief Supply Officer. 

Impossible Foods is a private company and does not publish financial data.  Given the declining sales and growing losses posted by competitor, Beyond Meat (BYND), it is presumed that Impossible Foods is experiencing similar headwinds including shrinking demand and slim margins. Despite eight infusions of venture capital, Impossible Foods Tape D® price declined from approximately $15 in January 2024 to approximately $2 at the beginning of January 2026.

Ten financing rounds from September 6, 2011, to November 23rd, 2021, raised close to $1.7 billion.  Investors include Horizons, Khosla, UVS, Temasek, Viking Global and XN Capital, among others. These companies now have little opportunity to recoup their investments given the limited prospects for the company to launch a successful initial public offering.

Both Impossible Foods and Beyond Meat have experienced declining sales both among retail stores and institutions.  Tapering demand is due to noncompetitive cost, inferior organoleptic qualities compared to real meat and poultry, the realization that plant-protein products are ultra- processed. These factors are in addition to reduced concern over livestock welfare, sustainability and the environment and an indifference to industry generated hype.

A recent article surveyed immunity to N1 neuraminidase in a population in British Columbia, Canada*.  Sera was obtained during August 2024 from 575 participants classified among ten age groups from one to 80 years of age.  Neuraminidase inhibition antibody titers were assessed by ELISA assay against H5N1 clade 2.3.4.4b.  In assessing N1 titers, 70 percent had detectable antibodies with half of the total yielding a low to moderate value, 32 percent at an intermediate threshold and 17 percent with a high concentration of antibody.  The level of antibody was consistent with previous exposure to H1N1 influenza pandemics in cohorts born from 1997 to 2003, many children exposed during the 2009 H1N1 outbreak and among those born before 1947.

The authors concluded that “a substantial proportion of the population has pre-existing anti-N1 against H5N1 with age-related variation”.

It is difficult to reconcile the low rate of infection attributed to H5N1 among workers with intensive exposure during depopulation and decontamination of infected poultry farms. A comprehensive epidemiologic survey of dairy and poultry workers has yet to be published.

It is generally conceded that workers at risk of exposure to H5N1 should be vaccinated against the prevailing seasonal influenza quadrivalent product to minimize the risk, albeit slight, of a recombinant event.  It is also suggested that dairy and poultry farm and processing workers should be vaccinated using an available H5N1 vaccine as deployed in Scandinavia for poultry and fur-farm workers.

*Skowronski, D. M., Cross-Reactive H5N1 Neuraminidase Antibodies by Agent Influenza Imprinting Cohorts of the Past Century: Population-Based Sero Survey, British Columbia, Canada J. Infectious Diseases.  doi.org/10.1093/infdis/jiag 030 (2026)

According to Ag Funder, financial support for cultivated meat enterprises has tanked.  Data confirms a reduction from close to $1 billion in 2021 to investment of only $65 million in 2024.  Evaporation of venture capital financing and rejection of funding rounds for existing companies has resulted in termination of operations.  Meatable in the Netherlands, considered the most capable of bringing forward a marketable product ceased operation in late 2025 concurrently with Believer Meats in the U.S. Industry observers ascribe the trend to the failure of startups to justify predictions of both consumer demand and their ability to produce. Hype only goes so far.

In the case of Believer Meats, the company embarked on major capital investment in buildings and installations without demonstrating their capacity to expand from pilot-scale production to commercial-level output using bioreactors that would be consistent with even miniscule demand.  Spokespersons for failed companies claim regulatory restraints but in both Western Europe and the U.S. there were few obstacles imposed by governments.  In contrast, many states in the U.S. and nations in Europe including France and Italy have enacted legislation banning either the production or sale of cultivated meat or have imposed rigorous labeling requirements as demanded by livestock producers.

Even if technical restraints had been overcome, it is doubtful whether demand for cultivated meat would have justified investment in facilities given concern over ultra-processed foods, a narrow range of products and non-competitive cost against “real” meat. Experience of the plant-based substitute-meat industry should have served as a warning to both venture capital companies and over enthusiastic proponents of cultivated meat based on sustainability and welfare.  These attributes have paled in significance during the past five years with cost and availability considerations that have become dominant in a post-COVID food market.